To differentiate high-risk vs. low-risk type 2 diabetic kidney disease using urine A/Cr and urine P/Cr

To review the evidence and practice points for proteinuria reduction and renal preservation strategies including BP control, treatment with ACE inhibition and SGLT-2 inhibition